Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration

2012309 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Ophthalmology

Volume 120, Issue 1, pp. 122-129

Field-Weighted Citation Impact: 21.39